All In MedTech

Device Trial Radar · NCT06797258

FlexHD® Pliable Investigation in Implant-Based Breast Reconstruction

Safety And Effectiveness Of FlexHD® Pliable Acellular Dermal Matrix In Implant-Based Breast Reconstruction

Last checked: Nov 21, 2026Latest source record: Apr 2, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

259

Planned (sponsor's estimate)

Start

Mar 26, 2025

Primary completion

Aug 2027

Study completion Aug 2027

Sponsor

Lead sponsor
Musculoskeletal Transplant FoundationAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
MCRA (an IQVIA business); Bruder Consulting International, LLC
First posted
Jan 28, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Female only, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Prospective, multi-center, single-arm clinical study in females undergoing immediate implant-based breast reconstruction using a pre-pectoral technique

Conditions

  • Implant Based Breast Reconstruction

Interventions

  • FlexHD® PliableDevice

    Acellular Dermal Matrix

  • No interventionOther

    Historical Control Arm

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Frequency of major complicationTime frame: 12 months

1 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Jonathan Heistein, MD Plastic & Reconstructive Surgery

    Fort Worth, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.